{
  "image_filename": "table_p7_det_6_004.png",
  "image_path": "Hsiao_et_al.__2023_/extracted/figures/table_p7_det_6_004.png",
  "image_type": "Table",
  "page_number": 7,
  "block_id": "det_6_004",
  "claim_id": "claim_000",
  "claim": "Flublok ensures identical antigenic match with WHO- and FDA-selected flu strains.",
  "supports_claim": false,
  "explanation": "A table summarizing demographic and clinical characteristics of trial participants vaccinated with recombinant influenza vaccine versus standard-dose vaccine. Columns list number and percentage of participants by sex, race or ethnic group, Hispanic ethnicity, coexisting illnesses (asthma, diabetes, COPD, coronary heart disease), and receipt of prior year influenza vaccine for each vaccine group and overall. does not support the claim because the table provides only participant demographics and clinical characteristics, with no information on antigenic matching to WHO- or FDA-selected flu strains Note: Limited to visible demographic data; no strain or antigenic match information is presented",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A table summarizing demographic and clinical characteristics of trial participants vaccinated with recombinant influenza vaccine versus standard-dose vaccine. Columns list number and percentage of participants by sex, race or ethnic group, Hispanic ethnicity, coexisting illnesses (asthma, diabetes, COPD, coronary heart disease), and receipt of prior year influenza vaccine for each vaccine group and overall.",
    "evidence_found": null,
    "reasoning": "does not support the claim because the table provides only participant demographics and clinical characteristics, with no information on antigenic matching to WHO- or FDA-selected flu strains",
    "confidence_notes": "Limited to visible demographic data; no strain or antigenic match information is presented"
  }
}